{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T23:19:17Z","timestamp":1774567157909,"version":"3.50.1"},"reference-count":73,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Roentgenology"],"published-print":{"date-parts":[[2002,1]]},"DOI":"10.1053\/sroe.2002.0000","type":"journal-article","created":{"date-parts":[[2006,6,5]],"date-time":"2006-06-05T17:59:08Z","timestamp":1149530348000},"page":"72-81","source":"Crossref","is-referenced-by-count":72,"title":["Drug-induced lung injury"],"prefix":"10.1053","volume":"37","author":[{"given":"Jeremy J.","family":"Erasmus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Page McAdams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santiago E.","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/sroe.2002.0000_bib1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1378\/chest.102.1.239","article-title":"Drug-induced pulmonary disease. An update","volume":"102","author":"Rosenow","year":"1992","journal-title":"Chest"},{"key":"10.1053\/sroe.2002.0000_bib2","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1183\/09031936.93.04040465","article-title":"Drug-induced lung disease: 1990 review","volume":"4","author":"Israel-Biet","year":"1991","journal-title":"Eur Respir J"},{"key":"10.1053\/sroe.2002.0000_bib3","first-page":"86","article-title":"Drug-induced pulmonary disease","volume":"10","author":"Rosenow","year":"1995","journal-title":"Sem Respir Infect"},{"key":"10.1053\/sroe.2002.0000_bib4","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0037-198X(05)80004-5","article-title":"Drug-induced pulmonary disorders","volume":"30","author":"Aronchick","year":"1995","journal-title":"Sem Roentgenol"},{"key":"10.1053\/sroe.2002.0000_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005382-199101000-00003","article-title":"Pathologic mechanisms of drug-induced lung disorders","volume":"6","author":"Pietra","year":"1991","journal-title":"J Thorac Imaging"},{"key":"10.1053\/sroe.2002.0000_bib6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0272-5231(21)00675-4","article-title":"The histopathology of pulmonary reactions to drugs","volume":"11","author":"Smith","year":"1990","journal-title":"Clin Chest Med"},{"key":"10.1053\/sroe.2002.0000_bib7","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1148\/131.2.299","article-title":"Radiographic patterns of drug-induced lung diseases","volume":"131","author":"Morrison","year":"1979","journal-title":"Radiology"},{"key":"10.1053\/sroe.2002.0000_bib8","first-page":"321","article-title":"Drug-induced pulmonary disease. Part 1: Cytotoxic drugs","volume":"133","author":"Cooper","year":"1986","journal-title":"Am Rev Respir Dis"},{"key":"10.1053\/sroe.2002.0000_bib9","first-page":"488","article-title":"Drug-induced pulmonary disease. Part 2. Noncytotoxic drugs","volume":"133","author":"Cooper","year":"1986","journal-title":"Am Rev Respir Dis"},{"key":"10.1053\/sroe.2002.0000_bib10","first-page":"231","article-title":"Drug-induced lung disease","volume":"42","author":"Cooper","year":"1997","journal-title":"Adv Intern Med"},{"key":"10.1053\/sroe.2002.0000_bib11","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1378\/chest.100.4.1120","article-title":"Drug-induced noncardiogenic pulmonary edema","volume":"100","author":"Reed","year":"1991","journal-title":"Chest"},{"key":"10.1053\/sroe.2002.0000_bib12","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0011-5029(94)90025-6","article-title":"Drug-induced pulmonary disease","volume":"40","author":"Rosenow","year":"1994","journal-title":"Dis Mon"},{"key":"10.1053\/sroe.2002.0000_bib13","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/0002-9343(81)90759-2","article-title":"Ara-C lung: Noncardiogenic pulmonary edema complicating cytosine arabinoside therapy of leukemia","volume":"70","author":"Haupt","year":"1981","journal-title":"Am J Med"},{"key":"10.1053\/sroe.2002.0000_bib14","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/BF02944269","article-title":"Pulmonary complications of cancer therapy","volume":"25","author":"Wesselius","year":"1999","journal-title":"Compr Ther"},{"key":"10.1053\/sroe.2002.0000_bib15","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1378\/chest.88.2.304","article-title":"Reactivation of bleomycin lung toxicity following oxygen administration. A second response to corticosteroids","volume":"88","author":"Gilson","year":"1985","journal-title":"Chest"},{"key":"10.1053\/sroe.2002.0000_bib16","series-title":"Surgical Pathology of Nonneoplastic Lung Disease","first-page":"81","article-title":"Pathology of drug-induced lung disease","author":"Meyers","year":"1997"},{"key":"10.1053\/sroe.2002.0000_bib17","series-title":"Spencer's pathology of the Lung","first-page":"551","article-title":"Drug-induced lung disease","author":"Kay","year":"1996"},{"key":"10.1053\/sroe.2002.0000_bib18","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0046-8177(87)80164-8","article-title":"Amiodarone lung: Pathologic findings in clinically toxic patients","volume":"18","author":"Myers","year":"1987","journal-title":"Hum Pathol"},{"key":"10.1053\/sroe.2002.0000_bib19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1148\/radiology.177.1.2399310","article-title":"Amiodarone pulmonary toxicity: CT findings in symptomatic patients","volume":"177","author":"Kuhlman","year":"1990","journal-title":"Radiology"},{"key":"10.1053\/sroe.2002.0000_bib20","first-page":"1691","article-title":"Pulmonary toxicity in long-term administration of BCNU","volume":"60","author":"Holoye","year":"1976","journal-title":"Cancer Treat Rep"},{"key":"10.1053\/sroe.2002.0000_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000478-200001000-00001","article-title":"Nonspecific interstitial pneumonia and the other idiopathic interstitial pneumonias: Classification and diagnostic criteria","volume":"24","author":"Katzenstein","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/sroe.2002.0000_bib22","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1001\/archinte.1987.00370010054014","article-title":"Amiodarone pulmonary toxicity: Clinical, radiologic, and pathologic correlations","volume":"147","author":"Kennedy","year":"1987","journal-title":"Arch Intern Med"},{"key":"10.1053\/sroe.2002.0000_bib23","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.2214\/ajr.171.6.9843306","article-title":"Nonspecific interstitial pneumonia with fibrosis: High-resolution CT and pathologic findings","volume":"171","author":"Kim","year":"1998","journal-title":"AJR Am J Roentgenol"},{"key":"10.1053\/sroe.2002.0000_bib24","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1056\/NEJM198501173120304","article-title":"Bronchiolitis obliterans organizing pneumonia","volume":"312","author":"Epler","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1053\/sroe.2002.0000_bib25","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1148\/radiographics.16.5.8888388","article-title":"The alphabet soup revisited: The chronic interstitial pneumonias in the 1990s","volume":"16","author":"McAdams","year":"1996","journal-title":"Radiographics"},{"key":"10.1053\/sroe.2002.0000_bib26","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/00004728-199711000-00015","article-title":"The spectrum of eosinophilic lung disease: radiologic findings","volume":"21","author":"Kim","year":"1997","journal-title":"J Comput Assist Tomogr"},{"key":"10.1053\/sroe.2002.0000_bib27","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2214\/ajr.164.2.7839958","article-title":"Diffuse pulmonary hemorrhage: Clinical, pathologic, and imaging features","volume":"164","author":"Primack","year":"1995","journal-title":"AJR Am J Roentgenol"},{"key":"10.1053\/sroe.2002.0000_bib28","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/00005792-197609000-00002","article-title":"Methotrexate-induced pneumonitis","volume":"55","author":"Sostman","year":"1976","journal-title":"Medicine (Baltimore)"},{"key":"10.1053\/sroe.2002.0000_bib29","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1164\/ajrccm.154.6.8970380","article-title":"Lung toxicity associated with cyclophosphamide use. Two distinct patterns","volume":"154","author":"Malik","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/sroe.2002.0000_bib30","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0959-8049(00)00350-6","article-title":"Risk factors of treatment-related death in chemotherapy and thoracic radiotherapy for lung cancer","volume":"37","author":"Ohe","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1053\/sroe.2002.0000_bib31","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/00004728-200011000-00027","article-title":"Gemcitabine pulmonary toxicity: CT features","volume":"24","author":"Boiselle","year":"2000","journal-title":"J Comput Assist Tomogr"},{"key":"10.1053\/sroe.2002.0000_bib32","first-page":"32","article-title":"Gemcitabine safety overview","volume":"23","author":"Green","year":"1996","journal-title":"Sem Oncol"},{"key":"10.1053\/sroe.2002.0000_bib33","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0169-5002(99)00081-1","article-title":"Etoposide-induced pulmonary toxicity","volume":"26","author":"Gurjal","year":"1999","journal-title":"Lung Cancer"},{"key":"10.1053\/sroe.2002.0000_bib34","first-page":"959","article-title":"Hypersensitivity reactions induced by etoposide","volume":"68","author":"O'Dwyer","year":"1984","journal-title":"Cancer Treat Rep"},{"key":"10.1053\/sroe.2002.0000_bib35","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1378\/chest.110.1.289","article-title":"Pulmonary infiltrates following administration of paclitaxel","volume":"110","author":"Ramanathan","year":"1996","journal-title":"Chest"},{"key":"10.1053\/sroe.2002.0000_bib36","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2165\/00003495-199855010-00002","article-title":"The taxoids. Comparative clinical pharmacology and therapeutic potential","volume":"55","author":"Eisenhauer","year":"1998","journal-title":"Drugs"},{"key":"10.1053\/sroe.2002.0000_bib37","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/1097-0142(19800115)45:2<236::AID-CNCR2820450207>3.0.CO;2-0","article-title":"Pulmonary toxicity of mitomycin","volume":"45","author":"Buzdar","year":"1980","journal-title":"Cancer"},{"key":"10.1053\/sroe.2002.0000_bib38","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1001\/jama.1979.03300260022020","article-title":"Early-onset cyclophosphamide-induced interstitial pneumonitis","volume":"242","author":"Spector","year":"1979","journal-title":"JAMA"},{"key":"10.1053\/sroe.2002.0000_bib39","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1136\/bmj.285.6343.696","article-title":"Fatal pulmonary fibrosis occurring during treatment with cyclophosphamide","volume":"285","author":"Burke","year":"1982","journal-title":"Br Med J (Clip Res Ed)"},{"key":"10.1053\/sroe.2002.0000_bib40","first-page":"361","article-title":"Extramedullary toxicity of a conditioning regimen containing busulphan, cyclophosphamide and etoposide in 84 patients undergoing autologous and allogenic bone marrow transplantation","volume":"15","author":"Crilley","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/sroe.2002.0000_bib41","first-page":"34","article-title":"The pulmonary toxicity of antineoplastic agents","volume":"9","author":"Ginsberg","year":"1982","journal-title":"Sem Oncol"},{"key":"10.1053\/sroe.2002.0000_bib42","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1378\/chest.84.4.492","article-title":"Additive pulmonary toxicity with melphalan and busulfan therapy","volume":"84","author":"Schallier","year":"1983","journal-title":"Chest"},{"key":"10.1053\/sroe.2002.0000_bib43","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1136\/thx.23.2.187","article-title":"Busulphan lung","volume":"23","author":"Heard","year":"1968","journal-title":"Thorax"},{"key":"10.1053\/sroe.2002.0000_bib44","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/1097-0142(197105)27:5<1074::AID-CNCR2820270511>3.0.CO;2-G","article-title":"Pulmonary lesions associated with busulfan therapy of chronic myelogenous leukemia","volume":"27","author":"Kirschner","year":"1971","journal-title":"Cancer"},{"key":"10.1053\/sroe.2002.0000_bib45","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/archinte.1969.00300170068013","article-title":"Effects of long-term administration of busulfan. Report of a patient with generalized nuclear abnormalities, carcinoma of vulva, and pulmonary fibrosis","volume":"124","author":"Feingold","year":"1969","journal-title":"Arch Intern Med"},{"key":"10.1053\/sroe.2002.0000_bib46","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1056\/NEJM198007243030403","article-title":"Prediction of BCNU pulmonary toxicity in patients with malignant gliomas: an assessment of risk factors","volume":"303","author":"Aronin","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1053\/sroe.2002.0000_bib47","first-page":"39","article-title":"Early pulmonary toxicity after administration of high-dose BCNU","volume":"65","author":"Litam","year":"1981","journal-title":"Cancer Treat Rep"},{"key":"10.1053\/sroe.2002.0000_bib48","doi-asserted-by":"crossref","first-page":"191","DOI":"10.7326\/0003-4819-90-2-191","article-title":"Pulmonary toxicity associated with bischloroethylnitrosourea (BCNU)","volume":"90","author":"Durant","year":"1979","journal-title":"Ann Intern Med"},{"key":"10.1053\/sroe.2002.0000_bib49","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/jnci\/85.8.640","article-title":"Acute lung injury following treatment with high-dose cyclophosphamide, cisplatin, and carmustine: pharmacodynamic evaluation of carmustine","volume":"85","author":"Jones","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/sroe.2002.0000_bib50","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1001\/jama.1980.03310070037025","article-title":"Rapidly progressive, fatal pulmonary fibrosis induced by carmustine","volume":"244","author":"Patten","year":"1980","journal-title":"JAMA"},{"key":"10.1053\/sroe.2002.0000_bib51","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1378\/chest.107.5.1355","article-title":"Late carmustine lung fibrosis. Age at treatment may influence severity and survival","volume":"107","author":"O'Driscoll","year":"1995","journal-title":"Chest"},{"key":"10.1053\/sroe.2002.0000_bib52","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJM199008093230604","article-title":"Active lung fibrosis up to 17 years after chemotherapy with carmustine (BCNU) in childhood","volume":"323","author":"O'Driscoll","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1053\/sroe.2002.0000_bib53","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1001\/jama.235.12.1253","article-title":"Fatal pulmonary reaction from low doses of bleomycin. An idiosyncratic tissue response","volume":"235","author":"Iacovino","year":"1976","journal-title":"JAMA"},{"key":"10.1053\/sroe.2002.0000_bib54","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1378\/chest.68.2.265","article-title":"Reversible interstitial pneumonitis associated with low dose bleomycin","volume":"68","author":"O'Neill","year":"1975","journal-title":"Chest"},{"key":"10.1053\/sroe.2002.0000_bib55","doi-asserted-by":"crossref","first-page":"861","DOI":"10.7326\/0003-4819-77-6-861","article-title":"Bleomycin, an antitumor antibiotic. Clinical experience in 274 patients","volume":"77","author":"Yagoda","year":"1972","journal-title":"Ann Intern Med"},{"key":"10.1053\/sroe.2002.0000_bib56","first-page":"217","article-title":"Cytotoxic drug-induced lung injury","volume":"3","author":"Snyder","year":"1988","journal-title":"Sem Respir Infect"},{"key":"10.1053\/sroe.2002.0000_bib57","doi-asserted-by":"crossref","first-page":"47","DOI":"10.7326\/0003-4819-88-1-47","article-title":"Bleomycin hypersensitivity pneumonitis","volume":"88","author":"Holoye","year":"1978","journal-title":"Ann Intern Med"},{"key":"10.1053\/sroe.2002.0000_bib58","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0011-5029(87)90021-6","article-title":"Drug-induced pulmonary disease","volume":"33","author":"Cooper","year":"1987","journal-title":"Dis Mon"},{"key":"10.1053\/sroe.2002.0000_bib59","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2214\/ajr.137.1.155","article-title":"Multiple pulmonary nodules: unusual manifestation of bleomycin toxicity","volume":"137","author":"Glasier","year":"1981","journal-title":"AJR Am J Roentgenol"},{"key":"10.1053\/sroe.2002.0000_bib60","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1148\/107.3.539","article-title":"Methotrexate therapy and pulmonary disease","volume":"107","author":"Everts","year":"1973","journal-title":"Radiology"},{"key":"10.1053\/sroe.2002.0000_bib61","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0889-857X(05)70366-5","article-title":"Methotrexate pulmonary toxicity","volume":"23","author":"Cannon","year":"1997","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1053\/sroe.2002.0000_bib62","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/1097-0142(19830101)51:1<34::AID-CNCR2820510109>3.0.CO;2-S","article-title":"Chemical pleuritis as the cause of acute chest pain following high-dose methotrexate treatment","volume":"51","author":"Urban","year":"1983","journal-title":"Cancer"},{"key":"10.1053\/sroe.2002.0000_bib63","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1136\/bmj.2.6091.867","article-title":"Pleurisy and methotrexate treatment","volume":"2","author":"Walden","year":"1977","journal-title":"Br Med J"},{"key":"10.1053\/sroe.2002.0000_bib64","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1002\/j.1875-9114.1998.tb03950.x","article-title":"Optimal management of amiodarone therapy: Efficacy and side effects","volume":"18","author":"Hilleman","year":"1998","journal-title":"Pharmacotherapy"},{"key":"10.1053\/sroe.2002.0000_bib65","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0272-5231(21)00677-8","article-title":"Mechanisms of amiodarone pulmonary toxicity","volume":"11","author":"Martin","year":"1990","journal-title":"Clin Chest Med"},{"key":"10.1053\/sroe.2002.0000_bib66","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0272-5231(21)00676-6","article-title":"Clinical aspects of amiodarone pulmonary toxicity","volume":"11","author":"Kennedy","year":"1990","journal-title":"Clin Chest Med"},{"key":"10.1053\/sroe.2002.0000_bib67","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00007611-199301000-00014","article-title":"Amiodarone pulmonary toxicity: A multidisciplinary review of current status","volume":"86","author":"Fraire","year":"1993","journal-title":"South Med J"},{"key":"10.1053\/sroe.2002.0000_bib68","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1378\/chest.96.3.512","article-title":"Hospitalizations for pulmonary reactions following nitrofurantoin use","volume":"96","author":"Jick","year":"1989","journal-title":"Chest"},{"key":"10.1053\/sroe.2002.0000_bib69","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/00006254-199606000-00021","article-title":"Nitrofurantoininduced pulmonary toxicity during pregnancy: A report of a case and review of the literature","volume":"51","author":"Boggess","year":"1996","journal-title":"Obstet Gynecol Surv"},{"key":"10.1053\/sroe.2002.0000_bib70","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1136\/thx.42.6.475","article-title":"Non fatal pulmonary haemorrhage associated with nitrofurantoin","volume":"42","author":"Bucknall","year":"1987","journal-title":"Thorax"},{"key":"10.1053\/sroe.2002.0000_bib71","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0009-9260(05)80161-8","article-title":"High-resolution computed tomography of drug-induced lung disease","volume":"46","author":"Padley","year":"1992","journal-title":"Clin Radiol"},{"key":"10.1053\/sroe.2002.0000_bib72","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1183\/09031936.97.10020265","article-title":"Drugs that may injure the respiratory system","volume":"10","author":"Foucher","year":"1997","journal-title":"Eur Respir J"},{"key":"10.1053\/sroe.2002.0000_bib73","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1136\/thorax.55.3.249","article-title":"Bronchiolitis obliterans organising pneumonia associated with the use of nitrofurantoin","volume":"55","author":"Cameron","year":"2000","journal-title":"Thorax"}],"container-title":["Seminars in Roentgenology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037198X02800463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037198X02800463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,4]],"date-time":"2024-02-04T17:30:48Z","timestamp":1707067848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037198X02800463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,1]]}},"alternative-id":["S0037198X02800463"],"URL":"https:\/\/doi.org\/10.1053\/sroe.2002.0000","relation":{},"ISSN":["0037-198X"],"issn-type":[{"value":"0037-198X","type":"print"}],"subject":[],"published":{"date-parts":[[2002,1]]}}}